FRAZIER KENNETH C
SEC insider (Form 3/4/5 filer). CIK 0001181175. Director at Eikon Therapeutics, Inc. (EIKN). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in MILLBRAE, CA.
Companies FRAZIER KENNETH C has filed insider reports for
- Eikon Therapeutics, Inc. (EIKN): Director
FRAZIER KENNETH C
CIK: 0001181175
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EIKN
Eikon Therapeutics, Inc.
Director